Dr. Anand Srivastava, Co-Founder


Co-founder of GIOSTAR. Dr. Anand Srivastava is a world-renowned authority in the field of stem cell science, also known as regenerative medicine.

Dr. Srivastava’s interdisciplinary approach to medicine stems from his almost two-decades-long experience in the field of stem cell research. He has expertise in protein biochemistry, molecular biology, immunology, stem cell biology, in utero transplantation, tissue targeting, clinical research, immunology, and gene therapy.

Dr. Srivastava is engaged in ongoing research and he has helped develop the stem cell research programs for prestigious institutions in the U.S, such as the University of California San Diego (UCSD), Salk Research Institute, San Diego, California, University of California Irvine (UCI), Burnham Institute of Medical Research, San Diego, California and University of California Los Angeles (UCLA).

Dr. Srivastava's efforts have been recognized on an international level, namely at conferences in the United States, Japan, Germany, Korea, China, and India. He has been published in leading medical journals.

His work was instrumental in the progression of stem cell science in the field of stem cell neurology at the University of California, San Diego (UCSD). Between 2002 and 2006, he was involved in studying the role of stem cells in repairing damaged portions of the animal brain. Dr. Srivastava’s research expertise in characterizing new genes are monumental for GIOSTAR to continue developing effective therapies and remain at the forefront of their everchanging field of regenerative medicine.

Dr. Srivastava was the recipient of the Congressional Award, as well as two consecutive JISTEC awards (Japan International Science and Technology Exchange)

He has translated his research into what GIOSTAR has become today: a global institute that focuses on developing the therapies for degenerative diseases, genetic diseases, and cancer.

Anand S. Srivastava, MS, PhD

Chairman & Cofounder of GIOSTAR 

Dr. Anand Srivastava is a proud recipient of the United States House of Representatives Certificate of Recognition for "Best Of Business" in recognition for co-founding GlOSTAR

Dr. Anand Srivastava cloned 23 genes while working for the government of Japan in 1998. In 1997 and 1998, he was awarded the Japan International Science and Technology Exchange Center (JISTEC) Award, a highly prestigious international scientific award. He is the only leading scientist to have earned this accolade twice. Dr. Srivastava also earned the Who’s Who award in 2005, 2010, 2014, and 2018.

Working at UC Irvine, Dr. Srivastava and the team of researchers conducted the first FDA Approved Human Clinical Trial with the Christopher & Dana Reeve Foundation for spinal cord injury, which started in 2007.

You now have direct access to a higher level of expertise for your stem cell therapy.

2614 Patriot Blvd., Unit A
Glenview, IL 60026
Phone: 844-446-7827
Office Hours

Get in touch